In contrast, Ctnnb1 (beta-catenin), Egfr and Pten mutations are associated with decreased CD8+ T cell infiltration in melanoma, non-small cell lung carcinoma and prostate cancer, respectively. Here, CTNNB1 is linked to prostate carcinoma.